US 12172969
Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
granted A61KA61K31/4164A61K31/565
Quick answer
US patent 12172969 (Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof) held by EVOFEM BIOSCIENCES, INC. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EVOFEM BIOSCIENCES, INC.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4164, A61K31/565, A61K31/567, A61K31/57